Medincell appoints Edna Venneker as Chief Medical Officer
Medincell (Euronext: MEDCL) announced the appointment of Edna Venneker, MD, as Chief Medical Officer.
Medincell (Euronext: MEDCL), a clinical- and commercial-stage biopharmaceutical licensing company developing long-acting injectable treatments across multiple therapeutic areas, today announced the appointment of Edna Venneker, MD, as Chief Medical Officer.Edna Venneker brings extensive internation…